跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Naropin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Naropin
Approved
STANDARD
Naropin
Astrazeneca AB
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
11ad8308f35b44da
Company
Astrazeneca AB
Type
Standard
Approval Details
Approval Id
11ad8308f35b44da
Drug Approval Philippines Name
Naropin
Product Name
Naropin
Registration Number
DR-XY22786
Brand Name
Naropin
Generic Name
Ropivacaine hydrochloride (as monohydrate)
Dosage Form
Prescription Drug Solution for Injection (Lumbar Epidural Administration)(Rx)
Dosage Strength
10 mg/mL (100 mg/ 10 mL)
Manufacturer
Astrazeneca AB
Importer
Aspen Philippines, Inc.
Company Detail Path
/organization/astrazeneca-ab
Issuance Date
29 December 2023
Expiry Date
01 February 2029
Pharmacologic Category
Local Anesthetic (Amide)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
11ad8308f35b44da
Type
Standard
Back to Philippines FDA Approvals